Glutamate antagonists: Deadly liaisons with cancer
AUTOR(ES)
Cavalheiro, Esper A.
FONTE
The National Academy of Sciences
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=33400Documentos Relacionados
- TGF-β antagonists: Why suppress a tumor suppressor?
- Calcium antagonists: A new class of therapeutic agents
- Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
- Calcium Antagonists: Rationale for Their Use in Exertional and Resting Angina Pectoris
- Glutamate antagonists limit tumor growth